Latest: Vidhi Specialty Food Ingredients Ltd Q2 FY27 results →All Q2 FY26 results →
VS

Vidhi Specialty Food Ingredients Ltd

Q2 FY26Chemicals & Petrochemicals

Vidhi Specialty Food Ingredients Q2 FY26 earnings call: Revenue & Margins

Q2 FY26 earnings call: what management said on revenue, margins and capex.

Price₹329
Market cap₹1.5K Cr
P/E28.9
Updated23 Aug 2026
Read4 min read

The short version

The company anticipates a significant shift towards high-value products, aiming to increase their revenue share from 15% to around 50% over the next 3-5 years, which will drive better sales realization and margin improvement. The company anticipates improved margins driven by a shift towards high-value, complex products with gross margins above 50%.

From Vidhi Specialty Food Ingredients Ltd's Q2 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • The company anticipates a significant shift towards high-value products, aiming to increase their revenue share from 15% to around 50% over the next 3-5 years, which will drive better sales realization and margin improvement.
  • Revenue from new complex products under R&D commercialization is expected to grow steadily over the next 6-8 quarters.
  • Volume capacity utilization at Dahej plant is at 65-70% and expected to reach full utilization by end of the year, supporting volume growth.
  • New capex plans at Dahej and Roha with a combined anticipated outlay of around INR100 crores will expand capacity and product portfolio, potentially enhancing future sales.

2 more points from Vidhi Specialty Food Ingredients Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Vidhi Specialty Food Ingredients Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Current anticipated capex outlay for Dahej and Roha plants combined is around INR 100 crores.
  • Already spent: INR 18 crores at Dahej (land acquisition) and approx. INR 15 crores at Roha.
  • Additional capex of INR 100 crores planned for these two facilities.
  • Capex activity at Roha includes a 4.5-acre land site, with pollution board approval received; construction to start within 2.5-3 months.
  • Capex at Dahej involves a newly acquired 16,894 sq. meters (4.5 acres) land, with necessary government permissions being obtained.
  • Engineering work ongoing; construction expected to complete within approximately 10 months at Roha.
  • No immediate capex planned for de-bottlenecking or replacing machinery at older plants.
  • Capex will be funded through a mix of internal accruals and some debt.

2 more points from Vidhi Specialty Food Ingredients Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

Guidance-ranked
1Shiv Texchem
Rev 1Mar 2
Rev 1Mar 3
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Vidhi Specialty Food Ingredients Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

See what Vidhi Specialty Food Ingredients Ltd said on order book & pipeline — free account, 30 seconds.

Vidhi Specialty Food Ingredients Ltd — Quarterly revenue & net profit

Revenue Net profit
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹137 Cr, net profit ₹18 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Chemicals & Petrochemicals this season

  • Gujarat Alkalies (Q2 FY26)

    2,136.64 Crores (Page 21). Key investor presentation takeaways from Gujarat Alkalies & Chemicals Ltd's Q2 FY26 investor presentation — and how it ranks against

  • Dynemic Products Ltd (Q2 FY26)

    Quarterly revenue for Q2 FY 25-26: ₹8,935 lakhs (Page 12, 10, 5) . Key investor presentation takeaways from Dynemic Products's Q2 FY26 investor presentation — a

  • Platinum Industries Ltd (Q2 FY26)

    Q2FY26 Revenue from Operations (Consolidated): INR 983.8 Mn, down 1% YoY from INR 996.4 Mn in Q2FY25. Key investor presentation takeaways from Platinum Industri

  • IVP Ltd (Q2 FY26)

    Revenue from Operations for Q2FY26: ₹146.95 crores . Key investor presentation takeaways from IVP's Q2 FY26 investor presentation — and how it ranks against sec

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Vidhi Specialty Food Ingredients Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Vidhi Specialty Food Ingredients Ltd Q2 FY26 results?

The company anticipates a significant shift towards high-value products, aiming to increase their revenue share from 15% to around 50% over the next 3-5 years, which will drive better sales realization and margin improvement. The company anticipates improved margins driven by a shift towards high-value, complex products with gross margins above 50%.

What is Vidhi Specialty Food Ingredients Ltd share price analysis?

Vidhi Specialty Food Ingredients Ltd currently shows a neutral. The stock trades at a P/E of 28.9 with a market cap of ₹1,548 Cr. Investors should review the full earnings analysis for detailed insights.

Is Vidhi Specialty Food Ingredients Ltd planning capital expenditure?

Current anticipated capex outlay for Dahej and Roha plants combined is around INR 100 crores. - Already spent: INR 18 crores at Dahej (land acquisition) and approx.

Keep Vidhi Specialty Food Ingredients Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.